"Transcriptome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The pattern of GENE EXPRESSION at the level of genetic transcription in a specific organism or under specific circumstances in specific cells.
| Descriptor ID |
D059467
|
| MeSH Number(s) |
G02.111.873.750 G05.297.700.750 G05.360.920
|
| Concept/Terms |
Gene Expression Profiles- Gene Expression Profiles
- Expression Profile, Gene
- Expression Profiles, Gene
- Gene Expression Profile
- Profile, Gene Expression
- Profiles, Gene Expression
- Transcriptome Profiles
- Profile, Transcriptome
- Profiles, Transcriptome
- Transcriptome Profile
- Gene Expression Signatures
- Expression Signature, Gene
- Expression Signatures, Gene
- Gene Expression Signature
- Signature, Gene Expression
- Signatures, Gene Expression
|
Below are MeSH descriptors whose meaning is more general than "Transcriptome".
Below are MeSH descriptors whose meaning is more specific than "Transcriptome".
This graph shows the total number of publications written about "Transcriptome" by people in this website by year, and whether "Transcriptome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 3 | 2 | 5 |
| 2012 | 8 | 15 | 23 |
| 2013 | 7 | 17 | 24 |
| 2014 | 13 | 15 | 28 |
| 2015 | 18 | 20 | 38 |
| 2016 | 22 | 22 | 44 |
| 2017 | 17 | 26 | 43 |
| 2018 | 11 | 30 | 41 |
| 2019 | 27 | 33 | 60 |
| 2020 | 24 | 37 | 61 |
| 2021 | 22 | 41 | 63 |
| 2022 | 19 | 19 | 38 |
| 2023 | 9 | 27 | 36 |
| 2024 | 16 | 28 | 44 |
| 2025 | 22 | 29 | 51 |
| 2026 | 22 | 9 | 31 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transcriptome" by people in Profiles.
-
Inaccurate interpretation of hypoxia signatures from transcriptomic analyses in neuro-oncology. Neoplasia. 2026 09; 79:101327.
-
Unveiling spatial heterogeneity in medulloblastoma: A multi-omics analysis of cellular state and geographical organization. Neuro Oncol. 2025 Jul 30; 27(6):1611-1627.
-
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma. Cancer Biomark. 2025 Jun; 42(6):18758592251344936.
-
Distinct systemic impacts of A?42 and Tau revealed by whole-organism snRNA-seq. Neuron. 2025 Jul 09; 113(13):2065-2082.e8.
-
Smooth muscle cells and fibroblasts in the ascending aorta exhibit minor differences between embryonic origins in angiotensin II-driven transcriptional alterations. Sci Rep. 2025 May 13; 15(1):16617.
-
Cell Population-resolved Multiomics Atlas of the Developing Lung. Am J Respir Cell Mol Biol. 2025 05; 72(5):484-495.
-
Multi-omics delineate growth factor network underlying exercise effects in an Alzheimer's mouse model. Alzheimers Dement. 2025 03; 21(3):e70024.
-
Acute MeCP2 loss in adult mice reveals transcriptional and chromatin changes that precede neurological dysfunction and inform pathogenesis. Neuron. 2025 02 05; 113(3):380-395.e8.
-
3D genome topology distinguishes molecular subgroups of medulloblastoma. Am J Hum Genet. 2024 12 05; 111(12):2720-2734.
-
A single-cell transcriptomic map of the developing Atoh1 lineage identifies neural fate decisions and neuronal diversity in the hindbrain. Dev Cell. 2024 08 19; 59(16):2171-2188.e7.